FindTrial
Sign In

An observational study to evaluate the pattern of multiple drug resistance pathogens seen in hospital acquired pneumonia patients admitted in tertiary care centres across India.Detail public title in in Protocol.

An observational study to evaluate the pattern of multiple drug resistance pathogens (Extended-Spectrum β-lactamases Producing Strains, Carbapenem Resistant Enterobacteriaceae and Methicillin Resistant Staphylococcus Aureus) seen in hospital acquired pneumonia patients admitted in tertiary care centres across India. - ASPI

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2015/05/005795
Enrollment
355
Registered
2015-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Hospital Acquired pneumonia Health Condition 2: J189- Pneumonia, unspecified organism

Interventions

None listed

Sponsors

Sanofi India Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient is >= 18 years of age and 2. The patient has been diagnosed as Hospital Acquired Pneumonia (HAP) as per CDC /NHSN Surveillance definition. 3. Bacteriological culture and sensitivity report showing presence of at least one causative pathogen. 4. Signed Informed consent obtained prior to any study related procedures.

Exclusion criteria

Exclusion criteria: 1. Are currently enrolled in, or discontinued within the last 30 days from, a clinical trial involving an investigational product or concurrently enrolled in any other type of medical research.

Design outcomes

Primary

MeasureTime frame
To evaluate the pattern of MDR pathogens (ESBL producing strains, CREs and MRSAs) seen in patients with hospital acquired pneumonia Timepoint: To evaluate the pattern of MDR pathogens (ESBL producing strains, CREs and MRSAs) seen in patients with hospital acquired pneumonia—

Secondary

MeasureTime frame
1. To evaluate the anti-microbial sensitivity pattern of MDR pathogens (ESBL producing strains, CREs and MRSAs) from patients with hospital acquired pneumonia. 2. To study the predisposing factors for MDR pathogens in these patients. Timepoint: Not applicable—

Countries

India

Contacts

Public ContactSujeet Ojha

Sanofi-Synthelabo India Limited

Deepa.Chodankar@sanofi.com9096867313

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026